Metabolic plasticity regulation on tumour microenvironment

Effects of metabolic plasticity regulation on tumour microenvironment. The stages of tumour development are also per stage of adapting and transforming for the microenvironment. (A) At the early stage of tumour development, CAAs produced by the death of tumour cells can be taken up by DCs, and CAAs are transmitted to the naive CD8+ T cells and differentiate into effector CD8+ T cells, then recognize the tumour cells and initiate the death of the tumour. This repetitive process is called CIC. The uptake of glucose, glutamine, and other nutrients can be utilized by glycolysis and OXPHOS. At the same time, OXPHOS can produce ROS, causing more damage to the tumour cells and then inducing DNA mutations, which increase its immunogenicity. Moreover, S1P and IL-7 can influence the differentiation of naive CD8+ T cells by S1P-driving OXPHOS and IL-7-driving glycolysis. Differentiated memory CD8+ T cells have better mitochondrial activity, and upon TCR and CD28 stimulation, their glycolytic metabolism can be promoted by activating the PI3K-mTOR-signaling pathway and differentiating into effector T cells. In addition, IFN-γ secreted by Th1 can activate macrophages to develop into M1-type macrophages but is unstable in an acidic microenvironment. NK cells can kill target cells directly, which is closely related to metabolic changes such as the activation of NK cells needed to switch its metabolism from mitochondrial oxidation to glycolysis. (B) In the progression of tumour development, the microenvironment favourable for the tumour was formed. The transition of OXPHOS to glycolysis or lactic acid can reduce cells’ immunogenicity, thus inhibiting the CIC. Excessive lactic acid (LA) produced by glycolysis is the inhibitory molecule of all anti-tumour immune cells, which can be absorbed by Treg cells, then suppressing effector CD8+ T cells. An acidic microenvironment caused by LA can make IFN-γ unstable. Thus, it inhibits the differentiation of Th1 cells and turns to Th2, which antagonizes the differentiation of M1-type macrophages. Except for tumour cells, CAFs are the main source of lactic acid, which is recruited by platelet-derived growth factor (PDGF) secreted through the tumour cells. Moreover, CAFs are the origin of TGF- β, which can induce FBP1 expression. This weakened the glycolytic level of NK cells, thereby inactivating NK cells. Angiogenesis is an important characteristic of tumour cells, and glycolysis contributes to this process. Lactic acid and hypoxia can promote this process by stabilizing HIF-1, VEGF, bFGF, VEGFR2, etc. The formation of vascular buds is crucial in the process of angiogenesis, which is guided and initiated by tip endothelial cells and stalk cells. Glycolysis can promote endothelial cells to compete for “tip” sites and “stalk” sites, and this process is accompanied by the overexpression of the glycolytic regulatory PFKFB3.
Metabolic plasticity regulation on tumour microenvironment

Publication

Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis (2023) Nan Niu, et al. Int J Mol Sci. 2023 Apr;24(8). Figure: F5.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates Th1 TH1 ncbigene_synonym NELFCD 51497
Homo sapiens Primates FBP1 FBP1 ncbigene_symbol FBP1 2203
Homo sapiens Primates TGF-B TGFB ncbigene_synonym TGFB1 7040
Homo sapiens Primates TGF-B TGFB famplex_relations TGFB2 7042
Homo sapiens Primates TGF-B TGFB famplex_relations TGFB3 7043
Homo sapiens Primates PDGF PDGF famplex_relations PDGFA 5154
Homo sapiens Primates PDGF PDGF famplex_relations PDGFB 5155
Homo sapiens Primates PDGF PDGF famplex_relations PDGFC 56034
Homo sapiens Primates PDGF PDGF famplex_relations PDGFD 80310
Homo sapiens Primates CAAs CAA ncbigene_synonym TSHZ1 10194
Homo sapiens Primates CAFS CAFS ncbigene_synonym TBX1 6899
Homo sapiens Primates CIC CIC ncbigene_symbol CIC 23152
Homo sapiens Primates CIC CIC ncbigene_synonym SLC25A1 6576
Homo sapiens Primates CD8+ CD8 ncbigene_synonym CD8A 925
Homo sapiens Primates CD8+ CD8 famplex_relations CD8B 926
Homo sapiens Primates Tip TIP ncbigene_synonym KAT5 10524
Homo sapiens Primates Tip TIP ncbigene_synonym METTL8 79828
Homo sapiens Primates Tip TIP ncbigene_synonym ITFG1 81533
Homo sapiens Primates Tip TIP ncbigene_synonym TIPRL 261726
Homo sapiens Primates bFGF BFGF ncbigene_synonym FGF2 2247
Homo sapiens Primates HIF-1a, HIF-1A ncbigene_synonym HIF1A 3091
Homo sapiens Primates VEGF, VEGF ncbigene_synonym VEGFA 7422
Homo sapiens Primates VEGF, VEGF famplex_relations VEGFB 7423
Homo sapiens Primates VEGF, VEGF famplex_relations VEGFC 7424
Homo sapiens Primates VEGF, VEGF famplex_relations VEGFD 2277
Homo sapiens Primates VEGF, VEGF famplex_relations PGF 5228
Homo sapiens Primates PFKFB3 PFKFB3 ncbigene_symbol PFKFB3 5209

Chemical mentions

Word Match MeSH Name ChEBI
DCs DCS (4R)-4-aminoisoxazolidin-3-one chebi:40009
Lactic acid Lactic acid 2-hydroxypropanoic acid chebi:78320

Disease mentions

Word Match MeSH Name DOID